UniProt ID | SHPS1_HUMAN | |
---|---|---|
UniProt AC | P78324 | |
Protein Name | Tyrosine-protein phosphatase non-receptor type substrate 1 | |
Gene Name | SIRPA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 504 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | Immunoglobulin-like cell surface receptor for CD47. Acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. May play a key role in intracellular signaling during synaptogenesis and in synaptic function (By similarity). Involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin. Mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells.. | |
Protein Sequence | MEPAGPAPGRLGPLLCLLLAASCAWSGVAGEEELQVIQPDKSVLVAAGETATLRCTATSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNNMDFSIRIGNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSNTAAENTGSNERNIYIVVGVVCTLLVALLMAALYLVRIRQKKAQGSTSSTRLHEPEKNAREITQDTNDITYADLNLPKGKKPAPQAAEPNNHTEYASIQTSPQPASEDTLTYADLDMVHLNRTPKQPAPKPEPSFSEYASVQVPRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
83 | Ubiquitination | RELIYNQKEGHFPRV CEEEEECCCCCCCCE | 63.12 | - | |
98 | Ubiquitination | TTVSDLTKRNNMDFS EEHHHHHHHCCCEEE | 61.50 | - | |
120 | Phosphorylation | PADAGTYYCVKFRKG CCCCCEEEEEEECCC | 7.21 | - | |
136 | Phosphorylation | PDDVEFKSGAGTELS CCCCEEECCCCCEEE | 38.91 | 29978859 | |
140 | Phosphorylation | EFKSGAGTELSVRAK EEECCCCCEEEEEEC | 32.97 | 29978859 | |
143 | Phosphorylation | SGAGTELSVRAKPSA CCCCCEEEEEECCCC | 11.88 | 29978859 | |
182 (in isoform 2) | Ubiquitination | - | 4.76 | 21890473 | |
182 (in isoform 1) | Ubiquitination | - | 4.76 | 21890473 | |
183 | Ubiquitination | SPRDITLKWFKNGNE CCCCEEEEEEECCCC | 41.77 | 21890473 | |
183 | Ubiquitination | SPRDITLKWFKNGNE CCCCEEEEEEECCCC | 41.77 | 21890473 | |
183 | Ubiquitination | SPRDITLKWFKNGNE CCCCEEEEEEECCCC | 41.77 | 21890473 | |
183 (in isoform 2) | Ubiquitination | - | 41.77 | - | |
186 | Ubiquitination | DITLKWFKNGNELSD CEEEEEEECCCCCCC | 63.93 | 22817900 | |
192 | Phosphorylation | FKNGNELSDFQTNVD EECCCCCCCCCCCCC | 30.15 | - | |
198 | Ubiquitination | LSDFQTNVDPVGESV CCCCCCCCCCCCCCC | 11.33 | 23000965 | |
204 | Phosphorylation | NVDPVGESVSYSIHS CCCCCCCCCEEEEEE | 15.50 | - | |
245 | N-linked_Glycosylation | DPLRGTANLSETIRV CCCCCCCCHHCCEEC | 43.89 | 16335952 | |
247 | O-linked_Glycosylation | LRGTANLSETIRVPP CCCCCCHHCCEECCC | 32.28 | 28657654 | |
259 | Phosphorylation | VPPTLEVTQQPVRAE CCCCEEEECCCCCCC | 16.47 | 30257219 | |
270 | N-linked_Glycosylation | VRAENQVNVTCQVRK CCCCCEEEEEEEEEE | 17.39 | 19159218 | |
272 | O-linked_Glycosylation | AENQVNVTCQVRKFY CCCEEEEEEEEEECC | 7.63 | 28657654 | |
272 | Phosphorylation | AENQVNVTCQVRKFY CCCEEEEEEEEEECC | 7.63 | 30257219 | |
292 | N-linked_Glycosylation | LTWLENGNVSRTETA EEEEECCCCCEEEEE | 39.92 | 19159218 | |
301 | Phosphorylation | SRTETASTVTENKDG CEEEEECEEEECCCC | 29.05 | 25307156 | |
319 | N-linked_Glycosylation | WMSWLLVNVSAHRDD EEEEEEEEEECCCCC | 23.23 | UniProtKB CARBOHYD | |
404 | Phosphorylation | RQKKAQGSTSSTRLH HHHHCCCCCCCCCCC | 17.03 | 26699800 | |
405 | Phosphorylation | QKKAQGSTSSTRLHE HHHCCCCCCCCCCCC | 33.26 | 29514088 | |
406 | Phosphorylation | KKAQGSTSSTRLHEP HHCCCCCCCCCCCCC | 31.26 | 25056879 | |
407 | Phosphorylation | KAQGSTSSTRLHEPE HCCCCCCCCCCCCCC | 20.03 | 25849741 | |
408 | Phosphorylation | AQGSTSSTRLHEPEK CCCCCCCCCCCCCCC | 36.70 | 26699800 | |
415 | Ubiquitination | TRLHEPEKNAREITQ CCCCCCCCCHHHHCC | 67.62 | 23000965 | |
424 | Phosphorylation | AREITQDTNDITYAD HHHHCCCCCCCCCEE | 25.60 | 28152594 | |
428 | Phosphorylation | TQDTNDITYADLNLP CCCCCCCCCEECCCC | 18.60 | 28152594 | |
429 | Phosphorylation | QDTNDITYADLNLPK CCCCCCCCEECCCCC | 9.84 | 20007894 | |
435 (in isoform 1) | Ubiquitination | - | 42.13 | 21890473 | |
436 | Ubiquitination | YADLNLPKGKKPAPQ CEECCCCCCCCCCCC | 83.18 | 2190698 | |
453 | Phosphorylation | EPNNHTEYASIQTSP CCCCCCCEEECCCCC | 13.55 | 10842184 | |
464 | Phosphorylation | QTSPQPASEDTLTYA CCCCCCCCCCCCCEE | 42.56 | 26356563 | |
467 | Phosphorylation | PQPASEDTLTYADLD CCCCCCCCCCEEEEC | 19.56 | 26356563 | |
469 | Phosphorylation | PASEDTLTYADLDMV CCCCCCCCEEEECEE | 20.82 | 26356563 | |
470 | Phosphorylation | ASEDTLTYADLDMVH CCCCCCCEEEECEEE | 10.96 | 25884760 | |
483 | Acetylation | VHLNRTPKQPAPKPE EECCCCCCCCCCCCC | 69.19 | 23749302 | |
492 | Phosphorylation | PAPKPEPSFSEYASV CCCCCCCCCHHCEEE | 39.48 | 28152594 | |
494 | Phosphorylation | PKPEPSFSEYASVQV CCCCCCCHHCEEEEC | 33.75 | 28152594 | |
494 | O-linked_Glycosylation | PKPEPSFSEYASVQV CCCCCCCHHCEEEEC | 33.75 | 28657654 | |
496 | Phosphorylation | PEPSFSEYASVQVPR CCCCCHHCEEEECCC | 11.72 | 27273156 | |
498 | Phosphorylation | PSFSEYASVQVPRK- CCCHHCEEEECCCC- | 16.51 | 27273156 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
429 | Y | Phosphorylation | Kinase | MATK | P42679 | GPS |
429 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
453 | Y | Phosphorylation | Kinase | MATK | P42679 | GPS |
453 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
470 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
470 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
496 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO2 | Q9UK22 | PMID:24658274 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SHPS1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHPS1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CCD57_HUMAN | CCDC57 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-270 AND ASN-292, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-245, AND MASSSPECTROMETRY. |